UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED 31ST DECEMBER, 2025 APPROVED BY THE BOARD AT THEIR MEETING HELD ON 3RD FEBRUARY, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shri Dinesh Mills Ltd announced its unaudited financial results (standalone and consolidated) for Q3 and the nine months ended 31 December 2025, approved by the Board on 3 February 2026. The statutory auditors, M/s. R.K. Doshi & Co. LLP, issued clean limited review reports with no qualifications. The Board also approved the reappointment of Ms. Reshma Patel as an Independent Director for five years, continuation of remuneration for Chairman & MD Shri Bharatbhai Patel, and an investment of about Rs 70.72 lakhs in 7,07,200 Optionally Convertible Preference Shares of its wholly-owned subsidiary Fernway Technologies Ltd. The company also confirmed that the divestment of its subsidiary Dinesh Remedies Limited was completed on 3 September 2025, and the auditors highlighted this as a note in their review (conclusion not modified).
Clean limited review reports reduce near-term audit risk for shareholders. The capital infusion into Fernway Technologies (a WOS) signals continued business support but uses internal cash without diluting outside shareholders. The completed sale of Dinesh Remedies streamlines the group structure but reduces consolidated scope going forward, which may make year-on-year comparisons less meaningful.